Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,038 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicenter Registry of Common Femoral Artery Disease Treated With Endovascular Revascularization Using Interwoven Nitinol Stents: An Observational Retrospective Study.
Horie K, Takahara M, Nakama T, Tobita K, Tanaka A, Shintani Y, Tsubakimoto Y, Yoshioka N, Hayakawa N, Sasaki S, Iwata Y, Ogata K, Takagi T, Doijiri T, Fujihara M. Horie K, et al. Among authors: takagi t. J Endovasc Ther. 2024 Feb 18:15266028241231472. doi: 10.1177/15266028241231472. Online ahead of print. J Endovasc Ther. 2024. PMID: 38369732
Endovascular Therapy with Interwoven Nitinol Stent Placement after Predilation for Heavily Calcified Femoropopliteal Artery Disease: Results of the BURDOCK Study.
Fujihara M, Takahara M, Iida O, Kawasaki D, Soga Y, Tobita K, Horie K, Takagi T, Okamoto S, Nakama T, Sasaki S, Tsubakimoto Y, Suematsu N. Fujihara M, et al. Among authors: takagi t. J Vasc Interv Radiol. 2023 Nov;34(11):1929-1937. doi: 10.1016/j.jvir.2023.07.023. Epub 2023 Jul 30. J Vasc Interv Radiol. 2023. PMID: 37527768
Survival Impact of Glucocorticoid Administration for Adverse Events During Immune Checkpoint Inhibitor Combination Therapy in Patients with Previously Untreated Advanced Renal Cell Carcinoma.
Yoshino M, Ishihara H, Nemoto Y, Mizoguchi S, Ikeda T, Nakayama T, Fukuda H, Yoshida K, Iizuka J, Shimmura H, Hashimoto Y, Kondo T, Takagi T. Yoshino M, et al. Among authors: takagi t. Target Oncol. 2024 May 31. doi: 10.1007/s11523-024-01069-6. Online ahead of print. Target Oncol. 2024. PMID: 38819770
3,038 results